Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Psychopathic Violent Offenders? Brains Can?t Understand Punishment

  • Brain region vulnerable to aging is larger in those with longevity gene variant

  • Things smell good for a reason

  • That's using your head: Brain regulates fat metabolism, potentially stopping disease

  • How creative are you? Depends where you're from

  • Drug candidates can block pathway associated with cell death in Parkinson's disease

  • MRIs link impaired brain activity to inability to regulate emotions in autism

  • Decisions on Future Childbearing in Women Diagnosed with a Meningioma

  • Age concern in largest ever study of heroin user deaths

  • Researchers find potential anti-cancer use for anti-epilepsy drug

  •